Winchester, MA, United States of America

Justin Boyd

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Aquinnah Pharmaceuticals, Inc., The Brigham and Women's Hospital, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin Boyd. Retrieved from https://idiyas.com/inventor/justin-boyd-5054u8s7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Justin Boyd

Introduction

Justin Boyd is an accomplished inventor based in Winchester, MA (US). He has made significant contributions to the field of biomedical research, particularly in understanding the mechanisms of cellular stress and inclusion formation.

Latest Patents

Justin Boyd holds a patent for the "Identification of compounds that disperse TDP-43 inclusions." This patent describes methods of modulating inclusion formation and stress granules in cells. The methods involve contacting a cell with an inclusion inhibitor. Additionally, the patent outlines methods for screening modulators of TDP-43 aggregation.

Career Highlights

Throughout his career, Justin has worked with notable organizations such as Aquinnah Pharmaceuticals, Inc. and The Brigham and Women's Hospital, Inc. His work has focused on innovative approaches to tackle complex biological challenges.

Collaborations

Justin has collaborated with esteemed colleagues, including Benjamin Wolozin and Marcie A. Glicksman. These partnerships have furthered research in the field and contributed to advancements in understanding TDP-43 inclusions.

Conclusion

Justin Boyd's contributions to the field of biomedical research through his patent and collaborations highlight his role as an innovative inventor. His work continues to influence the understanding of cellular mechanisms and potential therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…